Client Alerts

SPA/MF publishes 2025-2026 regulatory agenda for the fixed-odds betting sector

April 23rd, 2025

Client Alerts

ANVISA approves mandatory prescription retention for the sale of semaglutide, liraglutide, dulaglutide, exenatide, tirzepatide, and lixisenatide products

April 17th, 2025

Client Alerts

CONAR publishes 2024 activity report: Consumer complaints rise by 17%

April 9th, 2025

Client Alerts

BC calls for public consultation on tokenization of digital payments

April 7th, 2025

Client Alerts

The turning point for the regulation on Cannabis products

April 7th, 2025

Client Alerts

Brazilian Pharmacy Council authorizes pharmacists to prescribe legend medicines and establishes Specialist Qualification ID

March 28th, 2025

Client Alerts

Approval of financial statements and management accounts

March 28th, 2025

Client Alerts

SPA-MF launches initiative to denounce payment methods involved in illegal betting

March 27th, 2025

Client Alerts

Banks, Financial Services, Fintechs and Digital Assets Newsletter – February 2025

March 14th, 2025

Client Alerts

Unnecessary consent by fiduciary creditors is reinforced for registering fiduciary transfers of supervening real estate properties

March 10th, 2025

Client Alerts

ANVISA updates requirements for forced degradation studies and impurity parameters in synthetic and semi-synthetic medicines

February 27th, 2025

Client Alerts

ANVISA establishes optimized analysis procedure for the food industry

February 25th, 2025

1 … 4 5 6 7 8 … 31